SCHEMBL12249889

SCHEMBL12249889

COC(C)c1c[nH]c(C)c(C)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12249866 0.71
SCHEMBL1992010 0.66 LMNA (0.30)
SCHEMBL18680409 0.66 ALDH1A1 (0.37)
Ethane SCHEMBL16588819 0.65
SCHEMBL2115433 0.64
SCHEMBL12249888 0.61 SMN1; SMN2 (0.33)
SCHEMBL109259 0.60 GAA (0.40)
SCHEMBL9400147 0.59 NR4A2 (0.49)
SCHEMBL28515374 0.59
SCHEMBL38658521 0.58 ATAD2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026261-B2 neurodegenerative diseases; to remove free iron or iron accumulation in neural tissues; iron chelators; improved chemical stability, penetration through blood brain barrier; reacting 3-hydroxy-4-pyridinone/3-hydroxy-4-pyranone derivatives; 1-cyclopropyl-2-difluoromethyl-5-hydroxy-1H-pyridin-4-one APOTEX TECHNOLOGIES INC. (CA) 2011-09-27 US disclosed